TL;DR
This paper tackles the challenge of applying Natural Language Processing (NLP) techniques like Named Entity Recognition (NER) to clinical texts in low-resource languages. They propose a pipeline combining Neural Machine Translation (NMT) with cross-linguistic span alignment to transfer annotations from high-resource languages (like English) to languages with limited annotated data, achieving promising results for medication entities.
What Problem Does This Paper Address?
Extracting valuable information from clinical texts is crucial for improving healthcare and aiding decision-making. However, developing sophisticated NLP tools, particularly for Named Entity Recognition (NER), is heavily reliant on large, high-quality annotated datasets. While such resources are abundant for English, many other languages, like German, suffer from a significant lack of these annotated clinical datasets. This "low-resource" problem is exacerbated by varying data protection regulations and a lack of standardized annotation guidelines across institutions, making it difficult to share data and models. This paper aims to bridge this gap by enabling the transfer of NLP capabilities from well-resourced languages to low-resource clinical text domains.
Methods
The core of this work lies in a two-pronged approach to transfer annotations:
- Forward-Pass: This method involves translating the external, high-quality English annotated datasets into the target language (German in this case). These translated annotations are then used to train NLP models directly in the target language. The idea is that the translated text, along with its annotations, can serve as a proxy for native target-language data.
- Backward-Pass: Here, models are first trained on external English datasets. Then, the target language (German) clinical data is translated into English. The model makes predictions on this translated English data, and these predictions are subsequently re-aligned back to the original German text. This approach leverages pre-trained English biomedical models and attempts to mitigate translation-induced errors through re-alignment.
A key component in both approaches is cross-linguistic span alignment. This technique uses contextualized word embeddings (from models like multilingual BERT) to map tokens and their associated annotations between the source and target languages, even when sentence structures and word counts differ significantly after translation.
Datasets
- BRONCO Corpus: This is the primary German clinical dataset used in the study. It's a relatively small, fully anonymized dataset containing discharge reports for hepatocellular carcinoma and melanoma. It's notable for being one of the first publicly available German clinical text datasets with annotations for three entity classes: diagnosis, medication, and treatment. However, the clinical context is limited to the sentence level due to shuffling for anonymization.
- External English Datasets:
- SemEval-2013 drug-drug interaction (DDI) corpus: Used for identifying medication entities.
- NCBI disease corpus: Used for identifying diagnosis entities.
- i2b2/VA 2010 challenge data: Used for identifying treatment entities.
Key Insights and Ideas
- Cross-linguistic transfer is feasible, but not perfect: The study demonstrates that it's possible to leverage English NLP models and annotations for German clinical texts, especially for entities like "medication" where concepts are more universal.
- Backward-pass generally outperforms forward-pass: The approach of translating German text to English, predicting, and then re-aligning annotations back to German yielded better results than translating English annotations to German and training directly. This suggests that leveraging powerful pre-trained English biomedical models is highly beneficial.
- Annotation guideline differences are a major hurdle: The performance for "diagnosis" and "treatment" entities was significantly lower than for "medication." This is attributed to the lack of direct English equivalents for the German annotation guidelines and the inherent differences in how these concepts are categorized.
- Medication entities are more transferable: The relatively good performance on medication entities highlights that concepts with more universal representation across languages and less reliance on specific cultural or medical contexts are easier to transfer.
- Large biomedical models offer an advantage: Fine-tuning large, pre-trained biomedical language models (like Bio_Discharge_Summary_BERT) on translated data showed superior performance compared to non-biomedical models.
Key Results
- Medication entities: Achieved the best results, with an F1-score of 0.806 after re-alignment in the backward-pass approach.
- Diagnosis and Treatment entities: Showed limited success, with F1-scores just below 0.5, even after re-alignment. This indicates significant challenges in transferring these entity types.
- Backward-pass vs. Forward-pass: The backward-pass consistently yielded better scores across entity classes, though the difference was not always substantial.
- Large models superiority: Larger transformer-based models generally outperformed smaller ones, with GELECTRA-large achieving the highest F1-scores for medication.
Limitations and Future Work
- Limited language pair: The study focused solely on English-to-German transfer. The success of this approach on other language pairs will depend on the linguistic similarity (grammar, morphology) and the quality of translation and word alignment.
- Annotation guideline mismatch: The significant performance drop for diagnosis and treatment is directly linked to the difficulty in matching annotation guidelines between English and German datasets.
- Zero-resource limitations: The current approach is most effective when documents and annotation guidelines closely match.
- Future Work: The authors suggest exploring practical applications for other low-resource languages, investigating the impact of adding a few annotated samples (few-shot learning), and comparing against non-alignment baselines. They also propose further research into the effect of translation quality and the potential of multilingual models.
Summary updated